Primary Tumors of the Central and Peripheral Nervous System

Neurological Disorders: Course and Treatment: Second Edition

Volumn , Issue , 2003, Pages 827-863

  Weller, Michael ^a   Thomas, David G T ^b  

^a UNIVERSITY OF TÜBINGEN   (Germany)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84902224552     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-012125831-3/50257-4     Document Type: Chapter

References (161)

1. Alheit H., Saran F.H., Warrington A.P., Rosenberg I., Perks J., Jalali R., Shepherd S., Beardmore C., Baumert B., Brada M. Stereotactically guided conformal radiotherapy for meningiomas. Radiother. Oncol. 1999, 50:145-150.
2. Allison R.R., Schulsinger A., Vongtama V., Barry T., Shin K.H. Radiation and chemotherapy improve outcome in oligodendroglioma. Int. J. Radiat. Oncol. Biol. Phys. 1997, 37:399-403.
3. Anderson G.D., Lin Y.X., Berge C., Ojemann G.A. Absence of bleeding complications in patients undergoing cortical surgery while receiving valproate treatment. J. Neurosurg. 1997, 87:252-256.
4. Ashkan K., Casey A.T.H., D'Arrigo C., Harkness W.F., Thomas D.G.T. Benign central neurocytoma. A double misnomer?. Cancer 2000, 89:1111-1120.
5. Austin-Seymour M., Munzenrider J., Goitein M., Verhey L., Urie M., Gentry R., Birnbaum S., Ruotolo D., McManus P., Skates S., Ojemann R.G., Rosenberg A., Schiller A., Koehler A., Suit H. Fractionated proton radiation therapy of chordoma and low-grade chondrosarcoma of the base of the skull. J. Neurosurg. 1989, 70:13-17.
6. Balmaceda C., Heller G., Rosenblum M., Diez B., Villablanca J.G., Kellie S., Maher P., Vlamis V., Walker R.W., Leibel S., Finlay J.L., the First International Central Nervous System Germ Cell Tumor Study Chemotherapy without, irradiation-a novel approach for newly diagnosed CNS germ cell tumors: results of an international cooperative trial. J. Clin. Oncol. 1996, 14:2908-2915.
7. Bamberg M., Kortmann R.D., Calaminus G., Becker G., Meisner C., Harms D., Göbel U. Radiation therapy for intracranial germinoma: results from the German cooperative prospective trials MAKEI 83/86/89. J. Clin. Oncol. 1999, 17:2585-2592.
8. Bauman G., Lote K., Larson D., Stalpers L., Leighton C., Fisher B., Wara W., Macdonald D., Stitt L., Cairncross J.G. Pretreatment factors predict overall survival for patients with low-grade glioma: a recursive partitioning analysis. Int. J. Radiat. Oncol. Biol. Phys. 1999, 45:923-929.
9. Branzelli M.C., Patte C., Bouffet E., Couanet D., Habrand J.L., Portas M., Lajars O., Lutz P., Le Gall E., Kalifa C. Nonmetastatic intracranial germinoma. The experience of the French Society of Pediatric Oncology. Cancer 1997, 80:1792-1797.
10. Berthold F., Hero B. Neuroblastoma: current drug therapy recommendations as part of the total treatment approach. Drugs 2000, 59:1261-1277.
11. Bloom H.J.G., Bessell E.M. Medulloblastoma in adults: A review of 47 patients treated between 1952 and 1981. Int. J. Radiat. Oncol. Biol. Phys. 1990, 18:763-773.
12. Brada M., Sharpe G., Rajan B., Britton J., Wilkins P.R., Guerroro J., Hines F., Traish D., Ashley S. Modifying radical radiotherapy in high grade gliomas; shortening the treatment time through acceleration. Int. J. Radiat. Oncol. Biol. Phys. 1999, 43:287-292.
13. Brandes A.A., Rigon A., Zampieri P., Ermani M., Carollo C., Altavilla G., Turazzi S., Chierichetti F., Fiorentino M.V. Carboplatin and teniposide concurrent with radiotherapy in patients with glioblastoma multiforme. A phase II study. Cancer 1998, 82:355-361.
14. Brandes A.A., Ermani M., Turazzi S., Scelzi E., Berti F., Amistà P., Rotilio A., Licata C., Fiorentino M.V. Procarbazine and high-dose tamoxifen as a second-line regimen in recurrent high-grade gliomas: a phase II study. J. Clin. Oncol. 1999, 17:645-650.
15. Brandes A.A., Palmisano V., Monfardini S. Medulloblastoma in adults: clinical characteristics and treatment. Cancer Treat. Rev. 1999, 25:3-12.
16. Brat D.J., Hirose Y., Cohen K.J., Feuerstein B.G., Burger P.C. Astroblastoma: clinicopathologic features and chromosomal abnormalities defined by comparative genomic hybridization. Brain Pathol. 2000, 10:342-352.
17. Brem H., Piantadosi S., Burger P.C., Walker M., Selker R., Vick N.A., Black K., Sisti M., Brem S., Mohr G., Muller P., Morawetz R., Schold S.C. Placebo-controlled trial of safety and efficacy of intraoperative controlled delivery by biodegradable polymers of chemotherapy for recurrent gliomas. Lancet 1995, 345:1008-1012. Polymer Brain Tumor Treatment Group.
18. Buckner J.C., Peethambaram P.P., Smithson W.A., Groover R.V., Schomberg P.J., Kimmel D.W., Raffel C., O'Fallon J.R., Neglia J., Shaw E.G. Phase II trial of primary chemotherapy followed by reduced-dose radiation for CNS germ cell tumors. J. Clin. Oncol. 1999, 17:933-940.
19. Bullard D.E., Rawlings C.E., Phillips B., Cox E.B., Schold S.C., Burger P., Halperin E.C. Oligodendroglioma: an analysis of the vlaue of radiation therapy. Cancer 1987, 60:2179-2188.
20. Cairncross J.G., Macdonald D., Ludwin S., Lee D., Cascino T., Buckner J., Fulton D., Dropcho E., Stewart D., Schold C., Wainman N., Eisenhauer E. Chemotherapy for anaplastic oligodendroglioma. J. Clin. Oncol. 1994, 12:2013-2021. National Cancer Institute of Canada Clinical Trials Group.
21. Cairncross J.G., Ueki K., Zlatescu M.C., Lisle D.K., Finkelstein D.M., Hammond R.R., Silver J.S., Stark P.C., Macdonald D.R., Ino Y., Ramsay D.A., Louis D.N. Specific genetic predictors of chemotherapeutic response and survival in patients with anaplastic oligodendrogliomas. J. Natl. Cancer Inst. 1998, 90:1473-1479.
22. Celli P., Nofrone I., Palma L., Cantore G., Fortuna A. Cerebral oligodendroglioma: prognostic factors and life history. Neurosurgery 1994, 35:1018-1034.
23. Chamberlain M.C. Adjuvant combined modality therapy for malignant meningiomas. J. Neurosurg. 1996, 84:733-736.
24. Chamberlain M.C., Kormanik P.A. Salvage chemotherapy with paclitaxel for recurrent oligodendrogliomas. J. Clin. Oncol. 1997, 15:3427-3432.
25. Chang S.M., Kuhn J.G., Rizzo J., Robins H.I., Schold S.C., Spence A.M., Berger M.S., Mehta M.P., Bozik M.E., Pollack I., Gilbert M., Fulton D., Rankin C., Malec M., Prados M.D. Phase I study of paclitaxel in patients with recurrent malignant glioma: a North American Brain Tumor Consortium report. J. Clin. Oncol. 1998, 16:2188-2194.
26. Chang S.D., Meisel J.A., Hancock S.L., Martin D.P., McManus M., Adler J.R. Treatment of hemangioblastomas in von Hippel-Lindau disease with linear accelerator-based radiosurgery. Neurosurgery 1998, 43:28-34.
27. Chang S.M., Kuhn J.G., Robins H.I., Schold S.C., Spence A.M., Berger M.S., Mehta M.P., Bozik M.E., Pollack I., Schiff D., Gilbert M., Rankin C., Prados M.D. Phase II study of phenylacetate in patients with recurrent malignant glioma: a North American Brain Tumor Consortium report. J. Clin. Oncol. 1999, 17:984-990.
28. Chow E., Reardon D.A., Shah A.B., Jenkins J.J., Langston J., Heideman R.L., Sanford R.A., Kun L.E., Merchant T.E. Pediatric choroid plexus neoplasms. Int. J. Radiat. Oncol. Biol. Phys. 1999, 44:249-254.
29. Cloughesy T.F., Black K.L., Gobin Y.P., Farahani K., Nelson G., Villablanca P., Kabbinavar F., Viñeula P., Wortel C.H. Intra-arterial cereport (RMP-7) and carboplatin: a dose escalation study for recurrent malignant gliomas. Neurosurgery 1999, 44:270-279.
30. Couldwell W.T., Hinton D.R., Surnock A.A., DeGiorgio C.M., Weiner L.P., Aupzzo M.L., Masri L., Law R.E., Weiss M.H. Treatment of recurrent malignant gliomas with chronic oral high-dose tamoxifen. Clin. Cancer Res. 1996, 2:619-622.
31. Cozad S.C., Townsend P., Morantz R.A., Jenny A.B., Kepes J.J., Smalley S.R. Giomatosis cerebri. Results with radiation therapy. Cancer 1996, 78:789-793.
32. Crotty T.B., Scheithauer B.W., Young W.F., Davis D.H., Shaw E.G., Miller G.M., Burger P.C. Papillary craniopharyngioma: a clinicopathological study of 48 cases. J. Neurosurg. 1995, 83:206-214.
33. Curran W.J., Scott C.B., Weinstein A.S., Martin L.A., Nelson J.S., Phillips T.L., Murray K., Fischbach A.J., Yakar D., Schwade J.G., Corn B., Nelson D.F. Survival comparison of radiosurgery-eligible and-inelegible malignant glioma patients treated with hyperfractionated radiation therapy and carmustine: a report of radiaton, therapy oncology group 83-02. J. Clin. Oncol. 1993, 11:857-862.
34. Davis F.G., McCarthy B.J., Freels S., Kupelian V., Bondy M.L. The conditional probability of survival of patients with primary malignant brain tumors. Surveillance, epidemiology, and end results (SEER) data. Cancer 1999, 85:485-491.
35. DeAngelis L.M. Brain tumors. N. Engl. J. Med. 2001, 344:114-122.
36. DeAngelis L.M., Burger P.C., Green S.B., Carincross J.G. Malignant glioma: who benefits from adjuvant chemotherapy?. Ann. Neurol. 1998, 44:691-695.
37. Debus J., Hug E.B., Liebsch N.J., O'Farrel D., Finkelstein D., Efird J., Munzenrider J.E. Brainstem tolerance to conformal radiotherapy of skull base tumors. Int. J. Radiat. Oncol. Biol. Phys. 1997, 39:967-975.
38. DeCou J.M., Rao B.N., Parham D.M., Lobe T.M., Bowman L., Pappo A.S., Fontanesi J. Malignant peripheral nerve sheath tumors: the St. Jude Children's Research Hospital experience. Ann. Surg. Oncol. 1995, 2:524-529.
39. Donahue B., Scott C.B., Nelson J.S., Rotman M., Murray K.J., Nelson D.F., Banker F.L., Earle J.D., Fischbach J.A., Asbell S.O., Gaspar L.E., Markoe A.M., Curran W. Influence of an oligodendroglial component on the survival of patients with anaplastic astrocytomas: a report of radiation therapy oncology group 83-02. Int. J. Radiat. Oncol. Biol. Phys. 1997, 38:911-914.
40. Dropcho E.J., Soong S.J. The prognostic impact of prior low grade histology in patients with anaplastic gliomas; a case-control study. Neurology 1996, 47:684-690.
41. Ducatman B.S., Scheithauer B.W., Piepgras D.G., Reiman H.M., Ilstrup D.M. Malignant peripheral nerve sheath tumors. A clinicopathologic study of 120 cases. Cancer 1986, 57:2006-2021.
42. Dziuk T.W., Woo S., Butler E.B., Thornby J., Grossman R., Dennis W.S., Lu H., Carpenter L.S., Chiu J.K. Malignant meningioma: an indication for initial aggressive surgery and adjuvant radiotherapy. J. Neuro-Oncol. 1998, 37:177-188.
43. Engelhard H.H. The role of interstitial BCNU chemotherapy in the treatment of malignant glioma. Surg. Neurol. 2000, 53:458-464.
44. Epstein F.J., Farmer J.P., Freed D. Adult intramedullary spinal cord ependymomas: the result of surgery in 38 patients. J. Neurosurg. 1993, 79:204-209.
45. Esteller M., Garcia-Foncillas J., Andion E., Goodman S.N., Hidalgo O.F., Vanaclocha V., Baylin S.B., Herman J.G. Inactivation of the DNA-repair gene MGMT and the clinical response of gliomas to alkylating agents. N. Engl. J. Med. 2000, 343:1350-1354.
46. Evans A.E., Jenkin R.D.T., Sposto R., Ortega J.A., Wilson C.B., Wara W., Ertel I.J., Kramer S., Chang C.H., Leikin S.L., Hammond G.D. The treatment of medulloblastoma: results of a prospective randomized trial of radiation therapy with and without CCNU, vincristine and prednisone. J. Neurosurg. 1990, 72:572-582.
47. Fetell M.R., Grossman S.A., Fisher J.D., Erlanger B., Rowinsky E., Stockel J., Piantodosi S., the New Approaches to Brain Tumor Therapy Central Nervous System Consortium Preirradiation paclitaxel in glioblastoma multiforme: efficacy, pharmacology, and drug interactions. J. Clin. Oncol. 1997, 15:3121-3128.
48. Fine H.A., Dear K.B., Loeffler J.S., Black P.M., Canellos G.P. Meta-analysis of radiation therapy with and without adjuvant chemotherapy for malignant gliomas in adults. Cancer 1993, 71:2585-2597.
49. Fine H.A., Figg W.D., Jaeckle K., Wen P.Y., Kyritsis A.P., Loeffler J.S., Levin V.A., Black P.M., Kaplan R., Pluda J.M., Yung W.K. Phase II trial of the antiangiogenic agent thalidomide in patients with recurrent high-grade gliomas. J. Clin. Oncol. 2000, 18:708-715.
50. Finlay J.L., Goldman S., Wong M.C., Cairo M., Garvin J., August C., Cohen B.H., Stanley P., Zimmerman R.A., Bostrom B., Geyer J.R., Harris R.E., Sanders J., Yates A.J., Boyett J.M., Packer R.J. Pilot study of high-dose thiotepa and etoposide with autologous bone marrow rescue in children and young adults with recurrent CNS tumors. The Children's Cancer Group. J. Clin. Oncol. 1996, 14:2495-2503. Children's Cancer Group.
51. Ford J., Osborn C., Barton T., Bleehen N.M. A phase I study of intravenous RMP-7 with carboplatin in patients with progression of malignant glioma. Eur. J. Cancer 1998, 34:1807-1811.
52. Freeman C.R., Kepner J., Kun L.E., Sanford R.A., Kadota R., Mandell L., Friedman H. A detrimental effect of a combined chemotherapy-radiotherapy approach in children with diffuse intrinsic brain stem gliomas. Int. J. Radiat. Oncol. Biol. Phys. 2000, 47:561-564.
53. Friedman H.S., McLendon R.E., Kerby T., Dugan M., Bigner S.H., Henry A.J., Ashley D.M., Krischer J., Lovell S., Rasheed K., Marchev F., Seman A.J., Cokgor I., Rich J., Stewart E., Colvin O.M., Provenzale J.M., Bigner D.D., Haglund M.M., Friedman A.H., Modrich P.L. DNA mismatch repair and O6-alkylguanine-DNA alkyltransferase analysis and response to Temodal in newly diagnosed malignant glioma. J. Clin. Oncol. 1998, 16:3851-3857.
54. Fuller D., Bloom J.G. Radiotherapy for chordoma. Int. J. Radiat. Oncol. Biol. Phys. 1988, 15:331-339.
55. Galanis E., Buckner J.C., Schomberg P.J., Hammack J.E., Raffel C., Scheithauer B.W. Effective chemotherapy for advanced CNS embryonal tumors in adults. J. Clin. Oncol. 1997, 15:2939-2944.
56. Galanis E., Buckner J.C., Dinapoli R.P., Scheithauer B.W., Jenkins R.B., Wang C.H., O'Fallon J.R., Farr G. Clinical outcome of gliosarcoma compared with glioblastoma multiforme: North Central Cancer Treatment Group results. J. Neurosurg. 1998, 89:425-430.
57. Galanis E., Buckner J.C., Scheithauer B.W., Kimmel D.W., Schomberg P.J., Piepgras D.G. Management of recurrent menigeal hemangiopericytoma. Cancer 1998, 82:1915-1920.
58. Gannett D.E., Wisbeck W.M., Silbergeld D.L., Berger M.S. The role of postoperative irradiation in the treatment of oligodendroglioma. Int. J. Radiat. Oncol. Biol. Phys. 1994, 30:567-573.
59. Gaspar L.E., Mackenzie I.R.A., Gilbert J.J., Kaufmann J.C.E., Fisher B.F., Macdonald D.R., Cairncross J.G. Primary cerebral fibrosarcomas. Clinicopathologic study and review of the literature. Cancer 1993, 72:3277-3281.
60. Giannini C., Scheithauer B.W., Burger P.C., Brat D.J., Wollan P.C., Lach B., O'Neill B.P. Pleomorphic xanthroastrocytoma: what do we really know about it?. Cancer 1999, 85:2033-2045.
61. Giombini S., Solero C.L., Morello G. Late outcome of operations for supratentorial convexity meningiomas. Report on 207 cases. Surg. Neurol. 1984, 22:588-594.
62. Glaholm J., Bloom H.J.G., Crow J.H. The role of radiotherapy in the management of intracranial meningiomas: The Royal Marsden Hospital experience with 186 patients. Int. J. Radiat. Oncol. Biol. Phys. 1990, 18:755-761.
63. Goldsmith B.J., Wara W.M., Wilson C.B., Larson D.A. Postoperative irradiation for subtotally resected meningiomas. A retrospective analysis of 140 patients treated from 1967-1990. J. Neurosurg. 1994, 80:195-201.
64. Grant R., Liang B.C., Slattery J., Greenberg H.S., Junck L. Chemotherapy response criteria in malignant glioma. Neurology 1997, 48:1336-1340.
65. Green S.B., Byar D.P., Walker M.D., Pistenmaa D.A., Alexander E., Batzdorf U., Brooks W.H., Hunt W.E., Mealey J., Odom G.L., Paoletti P., Ransohoff J., Robertson J.T., Selker R.G., Shapiro W.R., Smith K.R., Wilson C.B., Strike T.A. Comparisons of carmustine, procarbazine, and high-dose methylprednisolone as additions to surgery and radio-therapy for the treatment of malignant glioma. Cancer Treat. Rep. 1983, 67:121-132.
66. Greenberg M.L. Chemotherapy of choroid plexus carcinoma. Child's Nerv. Syst. 1999, 15:571-577.
67. Grossman S.A., Wharam M., Sheidler V., Kleinberg L., Zeltzman M., Yue N., Piantadosi S. Phase II study of continuous infusion carmustine and cisplatin followed by cranial irradiation in adults with newly diagnosed high-grade astrocytoma. J. Clin. Oncol. 1997, 15:2596-2603.
68. Guthrie B.L., Ebersold M.J., Scheithauer B.W., Shaw E.G. Meningeal hemangiopericytoma: histopathological features, treatment, and long-term follow-up of 44 cases. Neurosurgery 1989, 25:514-522.
69. Habrand J.L., Ganry O., Couanet D., Rouxel V., Levy-Piedbois C., Pierre-Kahn A., Khalifa C. The role of radiation therapy in the management of craniopharyngioma: a 25-year experience and review of the literature. Int. J. Radiat. Oncol. Biol. Phys. 1999, 44:255-263.
70. Hardenbergh P.H., Golden J., Billet A., Scott R.M., Shrieve D.C., Silver B., Loeffler J.S., Tarbell N.J. Intracranial germinoma: the case for lower dose radiation therapy. Int. J. Radiat. Oncol. Biol. Phys. 1997, 39:419-426.
71. Helseth A., Mørk S.J. Primary intraspinal neoplasms in Norway, 1955 to 1986. A population-based survey of 467 patients. J. Neurosurg. 1989, 71:842-845.
72. Herrlinger V., Felsberg J., Küker W., Bornemann A., Plasswilm L., Knobbe C.B., Strik H., Wick W., Meyermann R., Dichgans J., Bamberg M., Reifenberger G., Weller M. Gliomatosis cerebri. Molecular pathology and clinical course. Ann. Neurol. 2002, 52:390-399.
73. Hess K.R. Extent of resection as a prognostic variable in the treatment of gliomas. J. Neuro-Oncol. 1999, 42:227-231.
74. Hildebrand J., Sahmoud T., Mignolet F., Brucher J.M., Afta D. Adjuvant therapy with dibromodulcitol and BCNU increases survival in adults with malignant gliomas. Neurology 1994, 44:1479-1483. EORTC Brain Tumor Group.
75. Hsu D.W., Efird J.T., Hedley-Whyte E.T. Progesterone and estrogen receptors in meningiomas: prognostic implications. J. Neurosurg. 1997, 86:113-120.
76. Ino Y., Zlatescu M.C., Sasaki H., Macdonald D.R., Stemmer-Rachamimov A.O., Jhung S., Ramsay D.A., Von Deimling A., Louis D.N., Cairncross J.G. Long survival and therapeutic responses in patients with histologically disparate high-grade gliomas demonstrating chromosome 1p loss. J. Neurosurg. 2000, 92:983-990.
77. Jakacki R.I., Cohen B.E., Jamison C., Mathews V.P., Arenson E., Longee D.C., Hilden J., Cornelius A., Needle M., Heilman D., Boaz J.C., Luerssen T.G. Phase II evaluation of interferonα-2a for progressive or recurrent craniopharyngiomas. J. Neurosurg. 2000, 92:255-260.
78. Jennings M.T., Gelman R., Hochberg F. Intracranial germ-cell tumors: natural history and pathogenesis. J. Neurosurg. 1985, 63:155-167.
79. Jennings M.T., Frenchman M., Shebab T., Johnson M.D., Creasy J., LaPorte K., Dettbarn W.D. Gliomatosis cerebri presenting as intractable epilepsy during early childhood. J. Child Neurol. 1995, 10:37-45.
80. Kaba S.E., DeMonte F., Bruner J.M., Kyritsis A.P., Jaeckle K.A., Symon L. Surgical management of hemangioblastoma of the spinal cord: a report of 18 cases. Neurosurgery 1989, 25:699-708.
81. Nazar G.B., Hoffman H.J., Becker L.E., Jenkin D., Humphreys R.P., Hendrick E.B. Infratentorial ependymomas in childhood: prognostic factors and treatment. J. Neurosurg. 1990, 72:408-417.
82. Needle M.N., Goldwein J.W., Grass J., Cnaan A., Bergman I., Molloy P., Sutton L., Zhao H., Garvin J.H., Phillips P.C. Adjuvant chemotherapy for the treatment of intracranial ependymoma of childhood. Cancer 1997, 80:341-347.
83. Nijjar T.S., Simpson W.J., Gadalla T., McCartney M. Oligodendroglioma. The Princess Margaret Hospital experience. (1958-1964). Cancer 1993, 71:4002-4006.
84. Nutting C., Brada M., Brazil L., Sibtain A., Saran F., Westbury C., Moore A., Thomas D.G.T., Traish D., Ashley S. Radiotherapy in the treatment of benign meningioma of the skull base. J. Neurosurg. 1999, 90:823-827.
85. Packer R.J. Childhood medulloblastoma: progress and future challenges. Brain Dev. 1999, 21:75-81.
86. Packer R.J., Sutton L.N., Elterman R., Lange B., Goldwein J., Nicholson H.S., Mulne L., Boyett J., D'Angio G., Wechsler-Jentzsch K., Reaman G., Cohen B.H., Bruce D.A., Rorke L.B., Molloy P., Ryan J., LaFond D., Evans A.E., Schut L. Outcome for children with medulloblastoma treated with radiation and cisplatin, CCNU, and vincristine chemotherapy. J. Neurosurg. 1994, 81:690-698.
87. Packer R.J., Ater J., Allen J., Phillips P., Geyer R., Nicholson H.S., Jakacki R., Kurczynski E., Needle M., Finlay J., Reaman G., Boyett J.M. Carboplatin and vincristine chemotherapy for children with newly diagnosed progressive low-grade gliomas. J. Neurosurg. 1997, 86:747-754.
88. Paleologos N.A., Macdonald D.R., Vick N.A., Cairncross J.G. Neoadjuvant procarbazine, CCNU, and vincristine for anaplastic and aggressive oligodendroglioma. Neurology 1999, 53:1141-1143.
89. Palma L., Celli P., Franco C., Cervoni L., Cantore G. Long-term prognosis for atypical and malignant meningiomas: a study of 71 surgical cases. J. Neurosurg. 1997, 86:793-800.
90. Paulino A.C., Melian E. Medulloblastoma and supratentorial primitive neuroectodermal tumors. An institutional experience. Cancer 1999, 86:142-148.
91. Pencalet P., Sainte-Rose C., Lellouch-Tubiana A., Kalifa C., Brunelle F., Sgouros S., Meyer P., Cinalli G., Zerah M., Pierre-Kahn A., Renier D. Papillomas and carcinomas of the choroid plexus in children. J. Neurosurg. 1998, 88:521-528.
92. Perry J.R., DeAngelis L.M., Schold S.C., Burger P.C., Brem H., Brown M.T., Curran W.J., Scott C.B., Prados M.D., Kaplan R., Cairncross J.G. Challenges in the design and conduct of phase III brain tumor therapy trials. Neurology 1997, 49:912-917.
93. Perry A., Scheithauer B.W., Stafford S.L., Lohse C.M., Wollan P.C. "Malignancy" in meningiomas: a clinicopathologic study of 116 patients, with grading implications. Cancer 1999, 85:2046-2056.
94. Philippon J.H., Clemenceau S.H., Fauchon F.H., Foncin J.F. Supratentorial low-grade astrocytomas in adults. Neurosurgery 1993, 32:554-559.
95. Polin R.S., Sheehan J.P., Chenelle A.G., Munoz E., Larner J., Phillips C.D., Cantrell R.W., Laws E.R., Newman S.A., Levine P.A., Jane J.A. The role of preoperative adjuvant treatment in the management of esthesioneuroblastoma: the University of Virginia experience. Neurosurgery 1998, 42:1029-1037.
96. Pollock B.E., Lundsford L.D., Kondziolka D., Flickinger J.C., Bissonette D.J., Kelsey S.F., Jannetta P.J. Outcome analysis of acoustic neuroma management: a comparison of microsurgery and stereotactic radiosurgery. Neurosurgery 1995, 36:215-229.
97. Post K.D., Eisenberg M.B., Catalano P.J. Hearing preservation in vestibular schwannoma surgery: what factors influence outcome?. J. Neurosurg. 1995, 83:191-196.
98. Prados M., Larson D.A., Lamborn K., McDermott M.W., Sneed P.K., Wara W.M., Chang S.M., Mack E.E., Krouwer H.G.J., Chandler K.L., Warnick R.E., Davis R.L., Rabbitt J.E., Malec M., Levin V.A., Gutin P.H., Phillips T.L., Wilson C.B. Radiation therapy and hydroxyurea followed by the combination of 6-thioguanine and BCNU for the treatment of primary malignant brain tumors. Int. J. Radiat. Oncol. Biol. Phys. 1998, 40:57-63.
99. Prados M.D., Scott C., Curran W.J., Nelson D.F., Leibel S., Kramer S. Procarbazine, lomustine, and vincristine (PCV) chemotherapy for anaplastic astrocytoma: a retrospective review of Radiation Therapy Oncology Group protocols comparing survival with carmustine or PCV adjuvant chemotherapy. J. Clin. Oncol. 1999, 17:3389-3395.
100. Rainov N.G. A phase III clinical evaluation of herpes simplex virus type 1 thymidine kinase and ganciclovir gene therapy as an adjuvant to surgical resection and radiation in adults with previously untreated glioblastoma multiforme. Human Gene Therapy 2000, 11:2389-2401. GL1328 International Study Group.
101. Rajan B., Ashley S., Gorman C., Jose C.C., Horwich A., Bloom H.J.G., Marsh H., Brada M. Craniopharyngeoma-long-term results followig limited surgery and radiotherapy. Radiother. Oncol. 1993, 26:1-10.
102. Rezai A.R., Woo H.W., Lee M., Cohen H., Zagzag D., Epstein F.J. Disseminated ependymomas of the central nervous system. J. Neurosurg. 1996, 85:618-624.
103. Richard S., David P., Marsot-Dupuch K., Giraud S., Beroud C., Resche F. Central nervous system hemangioblastomas, endolymphatic sac tumors, and von Hippel-Lindau disease. Neurosurg. Rev. 2000, 23:1-22.
104. Robertson P.L., DaRosso R.C., Allen J.C. Improved prognosis of intracranial non-germinoma germ cell tumors with multimodality therapy. J. Neuro-Oncol. 1997, 32:71-80.
105. Rochkind S., Blatt I., Sadeh M., Goldhammer Y. Extracranial metastases of medulloblastoma in adults: literature review. J. Neurol. Neurosurg. Psychiatry 1991, 54:80-86.
106. Rodriguez L.A., Prados M., Silver P., Levin V.A. Reevaluation of procarbazine for the treatment of recurrent malignant central nervous system tumors. Cancer 1989, 64:2420-2423.
107. Rubin G., Scienza R., Pasqualin A., Rosta L., Da Pian R. Craniocerebral epidermoids and dermoids: a review of 44 cases. Acta Neurochir. 1989, 97:1-16.
108. Samii M., Matthies C. Management of 1000 vestibular schwannomas (acoustic neuromas): surgical management and results with an emphasis on complications and how to avoid them. Neurosurgery 1997, 40:11-23.
109. Sawamura Y., Ikeda J., Shirato H., Tada M., Abe H. Germ cell tumours of the central nervous system: treatment consideration based on 111 cases and their long-term clinical outcomes. Eur. J. Cancer 1998, 34:104-110.
110. Sawamura Y., Shirato H., Ikeda J., Tada M., Ishii N., Kato T., Abe H., Fujeda K. Induction chemotherapy followed by reduced-volume radiation therapy for newly diagnosed central nervous system germinoma. J. Neurosurg. 1998, 88:66-72.
111. Schaller B., Kirsch E., Tolnay M., Mindermann T. Symptomatic granular cell tumor of the pituitary gland: case report and review of the literature. Neurosurgery 1998, 42:166-170.
112. Schild S.E., Scheithauer B.W., Schomberg P.J., Hook C.C., Kelly P.J., Frick L., Robinow J.S., Buskirk S.J. Pineal parenchymal tumors. Clinical, pathologic, and therapeutic aspects. Cancer 1993, 72:870-880.
113. Schild S.E., Scheithauer B.W., Haddock M.G., Schiff D., Burger P.C., Wong W.W., Lyons M.K. Central neurocytoma. Cancer 1997, 79:790-795.
114. Schild S.E., Nisi K., Scheithauer B.W., Wong W.W., Lyons M.K., Schomberg P.J., Shaw E.G. The results of radio-therapy for ependymomas: the Mayo clinic experience. Int. J. Radiat. Oncol. Biol. Phys. 1998, 42:953-958.
115. Schild S.E., Stafford S.L., Brown P.D., Wood C.P., Scheithauer B.W., Schomberg P.J., Wong W.W., Lyons M.K., Shaw E.G. The results of radiotherapy for brainstem tumors. J. Neuro-Oncol. 1998, 40:171-177.
116. Schrell U.M.H., Rittig M.G., Anders M., Koch U.H., Marschalek R., Kiesewetter F., Fahlbusch R. Hydroxyurea for treatment of unresectable and recurrent meningiomas. II. Decrease in the size of meningiomas in patients treated with hydroxyurea. J. Neurosurg. 1997, 86:840-844.
117. Schultheiss T.E., Kun L.E., Ang K.K., Stephens L.C. Radiation response of the central nervous system. Int. J. Radiat. Oncol. Biol. Phys. 1995, 31:1093-1112.
118. Scott J.N., Newcastle N.B., Brasher P.M.A., Fulton D., MacKinnon J.A., Hamilton M., Cairncross J.G., Forsyth P. Which glioblastoma multiforme patient will become a long-term survivor? A population-based study. Ann. Neurol. 1999, 46:183-188.
119. Seppälä M.T., Sainio M.A., Haltia M.J.J., Kinnunen J.J., Setälä K.H., Jääskelainen J.E. Multiple schwannomas: schwannomatosis or neurofibromatosis type 2?. J. Neurosurg. 1998, 89:36-41.
120. Shaw E.G., Scheithauer B.W., O'Fallon J.R., Davis D.H. Mixed oligoastrocytomas: a survival and prognostic factor analysis. Neurosurgery 1994, 34:577-582.
121. Shelton C. Unilateral acoustic tumors: how often do they recur after translabyrinthine removal?. Laryngoscope 1995, 105:958-966.
122. Shepherd S.F., Laing R.W., Cosgrove V.P., Warrington A.P., Hines F., Ashley S.E., Brada M. Hypofractionated stereotactic radiotherapy in the management of recurrent glioma. Int. J. Radiat. Oncol. Biol. Phys. 1997, 37:393-398.
123. Shibamato Y., Takahashi M., Sasai L. Prognosis of intracranial germinoma with syncytiotrophoblastic giant cells treated by radiation therapy. Int. J. Radiat. Oncol. Biol. Phys. 1997, 37:505-510.
124. Smalley S.R., Schomberg P.J., Earle J.D., Laws E.R., Scheithauer B.W., O'Fallon J.R. Radiotherapeutic considerations in the treatment of hemangioblastomas of the central nervous system. Int. J. Radiat. Oncol. Biol. Phys. 1990, 18:1165-1171.
125. Smith J.S., Perry A., Borell T.J., Lee H.K., O'Fallon J., Hosek S.M., Kimmel D., Yates A., Burger P.C., Scheithauer B.W., Jenkins R.B. Alterations of chromosome arms 1p and 19q as predictors of survival in oligodendrogliomas, astrocytomas, and mixed oligoastrocytomas. J. Clin. Oncol. 2000, 18:636-645.
126. Soffietti R., Rudà R., Bradac G.B., Schiffer D. PCV chemotherapy for recurrent oligodendrogliomas and oligoastrocytomas. Neurosurgery 1998, 43:1066-1073.
127. Solero C.L., Fornari M., Giombini S., Lasio G., Oliveri G., Cimino C., Pluchino F. Spinal meningiomas: review of 174 operated cases. Neurosurgery 1989, 125:153-160.
128. Streffer J., Schabet M., Bamberg M., Grote E.H., Meyermann R., Voigt K., Dichgans J., Weller M. A role for preirradiation PCV chemotherapy for oligodendroglial brain tumors. J. Neurol. 2000, 247:297-302.
129. Streffer J., Bitzer M., Schabet M., Dichgans J., Weller M. Response of radiochemotherapy-associated cerebral edema to a phytotherapeutic agent, H15. Neurology 2001, 561:1219-1221.
130. Strik H., Deininger M., Streffer J., Grote E., Wickboldt J., Dichgans J., Weller M., Meyermann R. Bcl-2 family protein expression in initial and recurrent glioblastomas: modulation by radiochemotherapy. J. Neurol. Neurosurg. Psychiatry 1999, 67:763-768.
131. Tait D.M., Thornton-Jones H., Bloom H.J.G., Lemerle J., Morris-Jones P. Adjuvant chemotherapy for medulloblastoma: the first multi-centre control trial of the International Society of Pediatric Oncology (SIOP I). Eur. J. Cancer 1990, 26:464-469.
132. Takakura K., Abe H., Tanaka R., Kitamura K., Miwa T., Takeuchi K., Yamamoto S., Kageyama N., Handa H., Mogami H., Nishimoto A., Uozumi T., Matsutani M., Nomura K. Effects of ACNU and radiotherapy on malignant glioma. J. Neurosurg. 1986, 64:53-57.
133. Tao M.L., Barnes P.D., Billett A.L., Leong T., Shrieve D.C., Scott R.M., Tarbell N.J. Childhood optic chiasm gliomas: radiographic response following radiotherapy and longterm clinical outcome. Int. J. Radiat. Oncol. Phys. 1997, 39:579-587.
134. Taylor B.W., Marcus R.B., Friedman W.A., Ballinger W.E., Million R.R. The meningioma controversy: postoperative radiation therapy. Int. J. Radiat. Oncol. Biol. Phys. 1988, 15:299-304.
135. Thiessen B., Finlay J., Kulkarni R., Rosenblum M.K. Astroblastoma: does histology predict biologcal behavior?. J. Neuro-Oncol. 1998, 40:59-65.
136. Brain tumours: Scientific basis, clinical investigation and current therapy 1980, 48. Butterworth, London. D.G.T. Thomas, D.I. Graham (Eds.).
137. Thomas D.G.T., Nouby R.M. Experience in 300 cases of CT-directed stereotactic surgery for lesion biopsy and aspiration of haematoma. Br. J. Neurosurg. 1989, 3:321-325.
138. Timmermann B., Kortmann R.D., Kühl J., Meisner C., Slavc I., Pietsch T., Bamberg M. Combined postoperative irradiation and chemotherapy for anaplastic ependymomas in childhood: results of the German prospective trials HIT 88/89 and HIT 91. Int. J. Radiat. Oncol. Biol. Phys. 2000, 46:287-295.
139. Tomlinson F.H., Scheithauer B.W., Hayostek C.J., Parisi J.E., Meyer F.B., Shaw E.G., Weiland T.L., Katzmann J.A., Jack C.R. The significance of atypia and histologic malignancy in pilocytic astrocytoma of the cerebellum: a clinicopathologic and flow cytometric study. J. Child Neurol. 1994, 9:301-310.
140. Valencak J., Dietrich W., Raderer M., Dieckmann K., Prayer D., Hainfellner J.A., Marosi C. Evidence of therapeutic efficacy of CCNU in recurrent choroid plexus papilloma. J. Neuro-Oncol. 2000, 49:263-268.
141. Van den Bent M.J., Kros J.M., Heimans J.J., Pronk L.C., Van Groeningen C.J., Krouwer H.G.J., Taphoorn M.J.B., Zonnenberg B.A., Tijssen C.C., Twijnstra A., Punt C.J.A., Boogerd W. Response rate and prognostic factors of recurrent oligodendroglioma treated with procarbazine, CCNU, and vincristine chemotherapy. Neurology 1998, 51:1140-1145. Dutch Neuro-oncology Group.
142. Vanuytsel L.J., Bessel E.M., Ashley S.E., Bloom H.J.G., Brada M. Intracranial ependymoma: long-term results of a policy of surgery and radiotherapy. Int. J. Radiat. Oncol. Biol. Phys. 1992, 23:313-319.
143. Vindlacheruvu R.R., Casey A.T.H., Thomas D.G.T. MRI-guided stereotactic brain biopsy: a review of 33 cases. Br. J. Neurosurgery 1999, 13:143-147.
144. Voges J., Sturm V., Lehrke R., Treuer H., Gauss C., Berthold F. Cystic craniopharyngeoma: long-term results after intracavitary irradiation with stereotactically applied colloidal beta-emitting radioactive sources. Neurosurgery 1997, 35:1001-1010.
145. Vuorinen V., Sallinen P., Haapasalo H., Visakorpi T., Kallio M., Jääskelainen J. Outcome of 31 intracranial haemangiopericytomas: poor predictive value of cell proliferation indices. Acta Neurochir. 1996, 138:1399-1408.
146. Walker M.D., Alexander E., Hunt W.E., MacCarty C.S., Mahaley M.S., Mealey J., Norrell H.A., Owens G., Ransohoff J., Wilson C.B., Gehan E.A., Strike T.A. Evaluation of BCNU and/or radiotherapy in the treatment of anaplastic gliomas. A cooperative clinical trial. J. Neurosurg. 1978, 49:333-343.
147. Walker M.D., Green S.B., Byar D.P., Alexander E., Batzdorf U., Brooks W.H., Hunt W.E., MacCarty C.S., Mahaley M.S., Mealey J., Owens G., Ransohoff J., Robertson J.T., Shapiro W.R., Smith K.R., Wilson C.B., Strike T.A. Randomized comparisons of radiotherapy and nitrosoureas for the treatment of malignant glioma after surgery. N. Engl. J. Med. 1980, 303:1323-1329.
148. Wallner K.E., Gonzales M., Sheline G.E. Treatment of oligodendrogliomas with or without post-operative irradiation. J. Neurosurg. 1988, 68:684-688.
149. Weller M., Schmidt C., Roth W., Dichgans J. Chemotherapy of human malignant glioma: prevention of efficacy by dexamethasone?. Neurology 1997, 48:1704-1709.
150. Weller M., Rieger J., Grimmel C., Van Meir E.G., De Tribolet N., Krajewski S., Reed J.C., Von Deimling A., Dichgans J. Predicting chemoresistance in human malignant glioma cells: the role of molecular genetic analyses. Int. J. Cancer 1998, 79:640-644.
151. Weller M., Streffer J., Wick W., Kortmann R.D., Heiss E., Küker W., Meyermann R., Dichgans J., Bamberg M. Preirradiation gemcitabine chemotherapy for newly diagnosed glioblastoma: a phase II study. Cancer 2001, 91:423-427.
152. Werner-Wasik M., Scott C.B., Nelson D.F., Gaspar L.E., Murray K.J., Fischbach J.A., Nelson J.S., Weinstein A.S., Curran W.J. Final report of a phase I/II trial of hyperfractionated and accelerated hyperfractionated radiation therapy with carmustine for adults with supratentorial malignant gliomas. Radiation Therapy Oncology Group Study 83-02. Cancer 1996, 77:1535-1543.
153. Whitaker S.J., Bessell E.M., Ashley S.E., Bloom H.J.G., Bell B.A., Brada M. Postoperative radiotherapy in the management of spinal cord ependymoma. J. Neurosurg. 1991, 74:720-728.
154. Wiegand D.A., Ojemann R.G., Fickel V. Surgical treatment of acoustic neuroma (vestibular schwannoma) in the United States: report from the Acoustic Neuroma Registry. Laryngoscope 1996, 106:58-66.
155. Wong W.W., Hirose T., Scheithauer B.W., Schild S.E., Gunderson L.L. Malignant peripheral nerve sheath tumor: analysis of treatment outcome. Int. J. Radiat. Oncol. Biol. Phys. 1998, 42:351-360.
156. Wong E.T., Hess K.R., Gleason M.J., Jaeckle K.A., Kyritsis A.P., Prados M.D., Levin V.A., Yung W.K. Out-comes and prognostic factors in recurrent glioma patients enrolled onto phase II clinical trials. J. Clin. Oncol. 1999, 17:2572-2578.
157. Yasargil M.G., Curcic M., Kis M., Siegenthaler G., Teddy P.J., Roth P. Total removal of craniopharyngiomas. Approaches and long-term results in 144 patients. J. Neurosurg. 1990, 73:3-11.
158. Younis G., Sawaya R., DeMonte F., Hess K.R., Albrecht S., Bruner J.M. Aggressive meningeal tumors: review of a series. J. Neurosurg. 1995, 82:17-27.
159. Yung W.K.A., Prados M.D., Yaga-Tur R., Rosenfeld S.S., Brada M., Friedman H.S., Albright R., Olson J., Chang S.M., O'Neill A.M., Friedman A.H., Bruner J., Yue N., Dugan M., Zaknoen S., Levin V.A. Multicenter phase II trial of temozolomide in patients with anaplastic astrocytoma or anaplastic oligoastrocytoma at first relapse. J. Clin. Oncol. 1999, 17:2762-2771. Temodal Brain Tumor Group.
160. Yung W.K.A., Albright R.E., Olson J., Fredericks R., Fink K., Prados M.D., Brada M., Spence A., Hohl R.J., Shapiro W., Glantz M., Greenberg H., Selker R.G., Vick N.A., Rampling R., Friedman H., Phillipps P., Bruner J., Yue N., Osoba D., Zaknocn S., Levin V.A. A phase II study of temozolomide vs. procarbazine in patients with glioblastoma multiforme at first relapse. Br. J. Cancer 2000, 83:588-593.
161. Zeltzer P.M., Boyett J.M., Finlay J.L., Albright A.L., Rorke L.B., Milstein J.M., Allen J.C., Stevens K.R., Stanley P., Li H., Wisoff J.H., Geyer J.R., McGuire-Cullen P., Stehbens J.A., Shurin S.B., Packer R.J. Metastasis stage, adjuvant treatment, and residual tumor are prognostic factors for medulloblastoma in children: conclusions from the Children's Cancer Group 921 randomized phase III study. J. Clin. Oncol. 1999, 17:832-845.